Stallergenes Greer
France - AntonyBiotechnology
Focus: Stallergenes Greer is a specialized biotechnology company focused on allergen desensitization therapies, headquartered in Antony, France. The company develops sublingual immunotherapy (SLIT) tablets targeting allergic rhinitis, asthma, and related allergic conditions.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Stallergenes Greer
AI assessmentNot HiringNo open roles listed right now. Follow Stallergenes Greer to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
10 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Oralair
Stable
Peak
Marketed sublingual immunotherapy product supporting commercial infrastructure and regulatory experience in SLIT tablets.
STALORAL® Birch 300 IR
Help build intelligence for Stallergenes Greer
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.